Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation

The role of risk analysis in polio eradication: modeling possibilities, probabilities and outcomes to inform choices

(2011) Kimberly M Thompson   Expert Review of Vaccines

Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population

(2011) Steven Wassilak et al.   JOURNAL OF INFECTIOUS DISEASES

Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials

(2011) T. Jacob John et al.   VACCINE

Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba

(2010) Sonia Resik et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

(2010) Roland W Sutter et al.   LANCET

Fractional Doses of Inactivated Poliovirus Vaccine in Oman

(2010) Ali Jafer Mohammed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Economic analysis of the global polio eradication initiative

(2010) Radboud J. Duintjer Tebbens et al.   VACCINE

Mucosal Immunity after Vaccination with Monovalent and Trivalent Oral Poliovirus Vaccine in India

(2009) Nicholas C. Grassly et al.   JOURNAL OF INFECTIOUS DISEASES

Priority Shifting and the Dynamics of Managing Eradicable Infectious Diseases

(2009) Radboud J. Duintjer Tebbens et al.   MANAGEMENT SCIENCE

The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses

(2008) Kimberly M. Thompson et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Monovalent Type 1 Oral Poliovirus Vaccine in Newborns

(2008) Nasr El-Sayed et al.   NEW ENGLAND JOURNAL OF MEDICINE